SCHEMBL7127665

SCHEMBL7127665

O=C(Oc1ccccc1C(=O)O)c1ccc(CO[N+](=O)[O-])cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.51
HSD17B10 Q99714 5/20 0.51
HPGD P15428 4/20 0.51
ALDH1A1 P00352 4/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA4 P22748 1/20 0.50
CA9 Q16790 1/20 0.50
ESR1 P03372 2/20 0.48
ESR2 Q92731 1/20 0.48
LMNA P02545 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
SLC6A3 Q01959 1/20 0.47
PTGS2 P35354 3/20 0.45
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
HMGB1 P09429 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14010502 0.86 KDM4E (0.47) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL16599001 0.83 CA12 (0.54) KDM4EALDH1A1CA12CA1CA2
SCHEMBL14010479 0.83 KDM4E (0.49) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL11280439 0.81 KDM4E (0.68) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL17986292 0.81 CA12 (0.51) KDM4EALDH1A1CA12CA1CA2
SCHEMBL15928842 0.81 CA12 (0.45) HSD17B10HPGDALDH1A1CA12CA1
SCHEMBL4322746 0.80 ALDH1A1 (0.50) KDM4EHSD17B10HPGDALDH1A1CA12
SCHEMBL4846409 0.78 ESR1 (0.69) KDM4EHSD17B10HPGDALDH1A1ESR1
SCHEMBL186313 0.78 CA12 (0.56) HPGDALDH1A1CA12CA1CA2
SCHEMBL11273464 0.78 KDM4E (0.64) KDM4EHSD17B10HPGDALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1336602-A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases Scaramuzzino, Giovanni (IT) 2003-08-20 EP disclosed